Sareum Holdings | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

3,543 results for “Sareum Holdings”

Trials

View all 2458 →

Breath-holding Spells and Its Management Study

120 participants · First posted Oct 4, 2024

Docosahexaenoic Acid on Breath Holding Spells in Children

60 participants · First posted May 29, 2019

Gaze Holding in Cerebellar Patients

22 participants · First posted Jul 9, 2014

Drugs

View all 151 →

DEP remdesivir (Starpharma Holdings)

Polyomavirus vaccine (BioE Holdings)

DEP gemcitabine (Starpharma Holdings)

Organizations

View all 162 →

Biglari Holdings

United States

BrightView Holdings

United States

Rafael Holdings

United States

News

View all 772 →

Sareum's SDC-1801 Advances to Phase II Trials for Psoriasis Following Positive Phase I Results

Sareum Holdings Raises £2.4 Million to Advance TYK2/JAK1 Inhibitor SDC-1801

Sareum Halts SDC-1801 Toxicology Study Due to Animal Welfare Concerns, Phase 2 Psoriasis Trial Delayed

Page 1 of 355